
Loading, please wait...

Loading, please wait...

Researchers are exploring new ways to combat malignant tumors, and a recent study highlights the potential of Cephaeline breast cancer ferroptosis induction. Cephaeline (CPL) is a bioactive compound found in the Ipecacuanha plant. While scientists previously knew it for other medicinal uses, this research demonstrates its ability to suppress breast cancer growth. Specifically, the study investigates how CPL influences cell viability and the molecular pathways involved in regulated cell death.
Consequently, results showed that CPL significantly inhibited cell proliferation in a dose-dependent manner. The IC50 values were approximately 38.89 nM for 4T1 cells and 50.29 nM for MDA-MB-231 cells. Furthermore, CPL suppressed cell migration and colony formation at higher concentrations. This suggests that the compound not only kills cancer cells but also prevents them from spreading. Additionally, the study measured intracellular iron and found significant changes after treatment.
The core finding involves the induction of ferroptosis, a form of iron-dependent cell death. Notably, CPL increased intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) levels. At the same time, it downregulated glutathione (GSH). Moreover, the researchers found that CPL acts through the p53/SLC7A11/GPX4 axis. By suppressing SLC7A11 and GPX4, the compound weakens the cell's antioxidant defenses. Therefore, lipid peroxides accumulate, leading to cell death.
However, the role of p53 appears crucial for this process. When researchers used siRNA to knock down p53, this intervention attenuated CPL's effects. This finding indicates that CPL requires a functioning p53 pathway to exert its anti-cancer activity. Overall, these findings position Cephaeline as a promising agent for future breast cancer therapies.
It is a bioactive alkaloid derived from the Ipecacuanha plant, traditionally used as an emetic but now studied for its anti-cancer properties.
It induces ferroptosis, an iron-dependent form of cell death, by disrupting the p53/SLC7A11/GPX4 antioxidant pathway.
The study found that knocking down p53 reduced the efficacy of Cephaeline, showing that the drug's anti-tumor effects are p53-dependent.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
Li X et al. Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis. Daru. 2026 Jun 19. doi: undefined. PMID: 42319734.
Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57-62.
Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 2020;147:15-21.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research reveals that Cephaeline (CPL) promotes ferroptosis in breast cancer by targeting the p53/SLC7A11/GPX4 axis, offering a potential new strategy for treatment.
4 months ago

Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back

A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
3 days back

New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
5 days back

A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 days back

A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 days back